http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-106349099-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C235-34 http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C07C231-02 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C231-02 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61P3-10 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C07C235-34 |
| filingDate | 2016-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-106349099-B |
| titleOfInvention | Caffeic acid-lysine and its derivative, preparation method and purposes |
| abstract | The invention discloses caffeic acid lysine and its derivative, preparation method and purposes, and structure is shown in formula I, R 1 、R 2 For H, OH, OCH 3 、OCOCH 3 , 3 methylbut, 2 enyl or isopentene group；R 3 For H, CH 3 、Bn、OCH 3 、OCOCH 3 、BnCH 2 , i Pr, t Bu or adamantyl.By the oral glucose tolerance test of mouse, show that caffeic acid lysine and its derivative can significantly reduce blood glucose, it was confirmed that the effect of caffeic acid lysine and its derivative anti-diabetic can prepare related drugs： |
| priorityDate | 2016-07-29-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 159.